We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GDMI Gets FDA Warning for Training Violations
GDMI Gets FDA Warning for Training Violations
February 2, 2010
The FDA has warned GDMI, which makes OTC antifungal treatments, about significant GMP violations at a facility in Texas, including flaws in sanitation and training.